14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $26.98 $26.98 Thursday, 8th Jun 2023 MYOV stock ended at $26.98. During the day the stock fluctuated 0% from a day low at $26.98 to a day high of $26.98.
90 days $26.98 $26.98
52 weeks $9.81 $27.06

Historical Myovant Sciences Ltd prices

Date Open High Low Close Volume
Nov 01, 2022 $26.75 $26.81 $26.73 $26.77 2 878 396
Oct 31, 2022 $26.72 $26.79 $26.71 $26.74 3 341 466
Oct 28, 2022 $26.73 $26.74 $26.70 $26.72 3 309 626
Oct 27, 2022 $26.78 $26.78 $26.68 $26.71 4 423 291
Oct 26, 2022 $26.70 $26.80 $26.68 $26.80 4 948 832
Oct 25, 2022 $26.73 $26.78 $26.68 $26.72 7 020 943
Oct 24, 2022 $26.61 $26.84 $26.56 $26.79 21 960 491
Oct 21, 2022 $24.26 $24.76 $24.26 $24.54 665 049
Oct 20, 2022 $24.15 $24.64 $23.95 $24.31 802 306
Oct 19, 2022 $24.47 $24.68 $24.08 $24.11 1 071 459
Oct 18, 2022 $25.20 $25.45 $24.41 $24.43 870 079
Oct 17, 2022 $24.88 $25.11 $24.44 $25.00 625 899
Oct 14, 2022 $25.06 $25.31 $24.27 $24.50 754 781
Oct 13, 2022 $24.27 $25.17 $24.18 $24.94 799 305
Oct 12, 2022 $24.76 $24.92 $24.27 $24.75 475 177
Oct 11, 2022 $24.25 $25.12 $24.05 $24.69 1 062 655
Oct 10, 2022 $24.91 $25.10 $23.81 $24.03 1 098 047
Oct 07, 2022 $24.83 $25.49 $24.47 $24.91 1 553 251
Oct 06, 2022 $24.79 $25.33 $24.36 $25.08 944 217
Oct 05, 2022 $25.01 $25.57 $24.75 $24.93 1 372 657
Oct 04, 2022 $24.31 $25.70 $23.77 $25.48 2 606 205
Oct 03, 2022 $23.54 $25.04 $23.45 $24.44 8 220 917
Sep 30, 2022 $17.48 $18.69 $17.48 $17.96 736 745
Sep 29, 2022 $18.00 $18.09 $17.40 $17.55 529 626
Sep 28, 2022 $17.55 $18.29 $17.45 $18.09 558 180
Click to get the best stock tips daily for free!

About Myovant Sciences Ltd

Myovant Sciences Ltd Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, whic... MYOV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT